Bruker Corporation Stock price

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 10:17:23 2024-03-28 am EDT 5-day change 1st Jan Change
93.76 USD -0.11% Intraday chart for Bruker Corporation -0.40% +27.78%
Sales 2024 * 3.26B Sales 2025 * 3.48B Capitalization 12.92B
Net income 2024 * 370M Net income 2025 * 464M EV / Sales 2024 * 4.12 x
Net Debt 2024 * 507M Net Debt 2025 * 325M EV / Sales 2025 * 3.81 x
P/E ratio 2024 *
37.6 x
P/E ratio 2025 *
29.3 x
Employees 9,707
Yield 2024 *
0.21%
Yield 2025 *
0.21%
Free-Float 53.4%
More Fundamentals * Assessed data
Dynamic Chart
Bruker Corporation Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO CI
Bruker Corporation completed the acquisition of Chemspeed Technologies AG. CI
Transcript : Bruker Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM
UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating MT
Transcript : Bruker Corporation Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 08:45 AM
Bruker to Acquire ELITechGroup for About $943 Million in Cash MT
Bruker Corporation entered into an agreement to acquire ELITech Group SAS from Tecfin S.À R.L. for approximately ?870 million. CI
Bruker Insider Sold Shares Worth $1,276,073, According to a Recent SEC Filing MT
Bruker Keeps Quarterly Dividend at $0.05 Per Share, Payable March 15 to Shareholders of Record on March 1 MT
Bruker Corporation Approves Payment of A Quarterly Cash Dividend, Payable on March 15, 2024 CI
UBS Adjusts Bruker Price Target to $94 From $86, Maintains Buy Rating MT
TD Cowen Adjusts Bruker's Price Target to $84 From $75, Keeps Market Perform Rating MT
Stifel Adjusts Bruker's Price Target to $81 From $63, Keeps Hold Rating MT
Leerink Partners Adjusts Bruker's Price Target to $90 From $86, Keeps Outperform Rating MT
Citigroup Adjusts Bruker's Price Target to $95 From $80, Keeps Buy Rating MT
More news
1 day+1.58%
1 week+0.96%
Current month+8.46%
1 month+12.14%
3 months+27.48%
6 months+50.73%
Current year+27.74%
More quotes
1 week
92.15
Extreme 92.15
94.64
1 month
85.86
Extreme 85.86
94.86
Current year
68.66
Extreme 68.66
94.86
1 year
53.79
Extreme 53.79
94.86
3 years
48.42
Extreme 48.42
94.86
5 years
30.78
Extreme 30.78
94.86
10 years
15.78
Extreme 15.778
94.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 91-01-31
Director of Finance/CFO 66 16-11-30
Public Communications Contact - 10-09-30
Members of the board TitleAgeSince
Director/Board Member 66 15-08-18
Director/Board Member 77 00-01-31
Director/Board Member 67 15-11-10
More insiders
Date Price Change Volume
24-03-28 93.89 +0.03% 18 319
24-03-27 93.86 +1.58% 327,350
24-03-26 92.4 -0.72% 442,881
24-03-25 93.07 -0.88% 586,134
24-03-22 93.9 -0.39% 494,606

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy & Supercon Technologies (BEST). The BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. The BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, and others. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
93.86 USD
Average target price
86 USD
Spread / Average Target
-8.37%
Consensus
  1. Stock
  2. Equities
  3. Stock Bruker Corporation - Nasdaq